Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
Stock. Additional stock would be great incentive.
Quali sono alcune delle cose migliori della tuo team?
My team works hard, is dedicated and supportive of one another.
Cosa ti piace di più del team di leadership?
The team is nimble and willing to take swift action with matters that affect business.
Che cosa ti rende più felice sul posto di lavoro?
It’s fulfilling to pull through initiatives and projects successfully. It’s also nice to feel appreciated or recognition for succe
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Executive team is supportive and generally willing to take swift action when needed. Innovation and urgency enable a healthy nimble environment.
Other Employee Reviews for Karyopharm Therapeutics
×